Provided by Tiger Fintech (Singapore) Pte. Ltd.

AVANOS MEDICAL

12.10
-0.2700-2.18%
Post-market: 12.100.00000.00%16:09 EDT
Volume:282.53K
Turnover:3.43M
Market Cap:559.55M
PE:-1.45
High:12.29
Open:12.18
Low:12.06
Close:12.37
Loading ...

Avanos Medical Announces Appointment of David Pacitti as Chief Executive Officer

THOMSON REUTERS
·
17 Mar

Avanos Medical Announces Appointment of David Pacitti as Chief Executive Officer

PR Newswire
·
17 Mar

MIDEAST STOCKS-Major Gulf markets gain on China stimulus prospects

Reuters
·
17 Mar

Do Options Traders Know Something About Avanos (AVNS) Stock We Don't?

Zacks
·
11 Mar

New Strong Sell Stocks for March 3rd

Zacks
·
03 Mar

Stock Track | Avanos Medical Plummets 5.51% as Transformation Challenges and 2025 Headwinds Weigh on Outlook

Stock Track
·
28 Feb

Avanos Medical Full Year 2024 Earnings: US$8.40 loss per share (vs US$0.21 loss in FY 2023)

Simply Wall St.
·
27 Feb

Q4 2024 Avanos Medical Inc Earnings Call

Thomson Reuters StreetEvents
·
27 Feb

Avanos Medical Inc (AVNS) Q4 2024 Earnings Call Highlights: Strong Organic Growth Amidst ...

GuruFocus.com
·
27 Feb

BUZZ-Avanos Medical rises on Q4 sales beat

Reuters
·
27 Feb

Avanos Medical Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
26 Feb

Avanos Medical (AVNS) Q4 Earnings and Revenues Surpass Estimates

Zacks
·
26 Feb

Avanos Medical: Q4 Earnings Snapshot

Associated Press Finance
·
26 Feb

Stock Track | Avanos Medical Plunges Over 10% in Pre-Market on Dismal Q4 Results and Weak Guidance

Stock Track
·
26 Feb

Avanos Medical Q4 Adj $0.43 Beats $0.40 Estimate, Sales $179.60M Beat $177.23M Estimate

Benzinga
·
26 Feb

BRIEF-Avanos Medical Q4 Sales USD 179.6 Million

Reuters
·
26 Feb

Avanos Medical Q4 Net Income USD -397.3 Million

THOMSON REUTERS
·
26 Feb

Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 Results

PR Newswire
·
26 Feb

Avanos Medical Inc expected to post earnings of 40 cents a share - Earnings Preview

Reuters
·
24 Feb

Avanos Medical (AVNS) Soars 7.2%: Is Further Upside Left in the Stock?

Zacks
·
28 Jan